|
|
Total
(n=1,240) |
Prevalence of Lipohypertrophy
|
| Overall
(n=1240) |
Men
(n=628) |
Women
(n=612) |
| Gender |
|
|
|
|
| Men |
628 (50.6) |
242 (38.5) |
- |
- |
| Women |
612 (49.4) |
328 (53.6) |
- |
- |
| P value |
|
<0.001 |
|
|
| Age (years) |
|
|
|
|
| 18-34 |
471 (38.0) |
211 (44.8) |
69 (32.7) |
142 (67.3) |
| 35-49 |
591 (47.7) |
266 (45.0) |
135 (50.8) |
131 (49.2) |
| 50-78 |
178 (14.3) |
93 (52.2) |
38 (40.9) |
55 (59.1) |
| P value |
|
0.2 |
0.3 |
0.3 |
| Skin color |
|
|
|
|
| White |
692 (55.8) |
298 (43.1) |
148 (49.7) |
150 (50.3) |
| Non-white |
548 (44.2) |
272 (49.6) |
94 (34.6) |
178 (65.4) |
| P value |
|
0.02 |
0.8 |
0.005 |
| Years at school |
|
|
|
|
| <12 |
1,097 (88.5) |
504 (45.9) |
199 (39.5) |
305 (60.5) |
| ≥ 12 |
143 (11.5) |
66 (46.2) |
43 (65.2) |
23 (34.8) |
| P value |
|
1.0 |
0.17 |
0.5 |
| Smoking (pack-years) |
|
|
|
|
| Never-smoker |
422 (34.0) |
221 (52.4) |
81 (36.7) |
140 (63.3) |
| < 20 |
498 (40.2) |
211 (42.4) |
87 (41.2) |
124 (58.8) |
| ≥ 20 |
320 (25.8) |
138 (43.1) |
74 (53.6) |
64 (46.4) |
| P value |
|
0.005 |
0.15 |
0.06 |
| Physical activity |
|
|
|
|
| Active |
716 (57.7) |
324 (45.3) |
114 (35.2) |
210 (64.8) |
| Inactive or sedentary |
524 (42.3) |
246 (46.9) |
128 (52.0) |
118 (48.0) |
| P value |
|
0.6 |
0.008 |
0.2 |
| Binge drinking |
|
|
|
|
| Yes |
211 (17.0) |
91 (43.1) |
56 (61.5) |
35 (38.5) |
| No |
1,029 (83.0) |
479 (46.6) |
186 (38.8) |
293 (61.2) |
| P value |
|
0.6 |
0.9 |
0.8 |
| Body mass index (kg/m2) |
|
|
|
|
| < 25 |
708 (57.1) |
223 (31.5) |
94 (42.2) |
129 (57.8) |
| 25–29.9 |
380 (30.6) |
220 (57.9) |
105 (47.7) |
115 (52.3) |
| ≥ 30 |
152 (12.3) |
127 (83.6) |
43 (33.9) |
84 (66.1) |
| P value |
|
<0.001 |
<0.001 |
<0.001 |
| Years since HIV diagnosis |
| <3 |
485 (39.1) |
206 (42.5) |
82 (39.8) |
124 (60.2) |
| 3-5 |
350 (28.3) |
169 (48.3) |
73 (43.2) |
96 (56.8) |
| ≥ 6 |
404 (32.6) |
195 (48.3) |
87 (44.6) |
108 (55.4) |
| P value |
|
0.14 |
0.19 |
0.4 |
| Currently on HAART |
|
|
|
|
| Yes |
815 (65.7) |
409 (50.2) |
167 (40.8) |
242 (59.2) |
| No |
425 (34.3) |
161 (37.9) |
75 (46.6) |
86 (53.4) |
| P value |
|
<0.001 |
0.4 |
<0.001 |
| CD4 count (cel/mm3) (n=1,227) |
| <350 |
476 (38.8) |
193 (40.5) |
86 (44.6) |
107 (55.4) |
| ≥ 350 |
751 (61.2) |
372 (49.5) |
153 (41.1) |
219 (58.9) |
| P value |
|
0.002 |
0.06 |
0.03 |
| HIV-RNA viral load (n=1,221) |
| Undetectable |
713 (57.5) |
280 (39.3) |
124 (44.3) |
156 (55.7) |
| Detectable |
508 (42.5) |
282 (55.5) |
113 (40.1) |
169 (59.9) |
| P value |
|
<0.001 |
<0.001 |
<0.001 |
| Total cholesterol (mg/dL) (n=1,226) |
| <200 |
854 (69.7) |
352 (41.2) |
148 (42.0) |
204 (58.0) |
| ≥ 200 |
372 (30.3) |
214 (57.5) |
90 (42.1) |
124 (57.9) |
| P value |
|
<0.001 |
<0.001 |
0.001 |
| HDL (mg/dL) (n=1,226) |
|
|
|
|
| <35 |
152 (12.4) |
50 (32.9) |
28 (56.0) |
22 (44.0) |
| ≥ 35 |
1,074 (87.6) (86.7) |
516 (48.0) |
210 (40.7) |
306 (59.3) |
| P value |
|
<0.001 |
0.006 |
0.3 |
| LDL (mg/dL) (n=1,225) |
|
|
|
|
| <130 |
966 (78.9) |
424 (43.9) |
188 (44.3) |
236 (55.7) |
| ≥ 130 |
259 (21.1) |
142 (54.8) |
50 (35.2) |
92 (64.8) |
| P value |
|
0.002 |
0.04 |
0.1 |
| Triglycerides (mg/dL) (n=1,227) |
| <150 |
787 (64.1) |
316 (40.2) |
107 (33.9) |
209 (66.1) |
| ≥150 |
440 (35.9) |
251 (57.0) |
132 (52.6) |
119 (47.4) |
| P value |
|
<0.001 |
<0.001 |
<0.001 |
| Fasting glucose (mg/dL) (n=1,226) |
| <126 |
1,185 (96.7) |
538 (45.4) |
223 (41.4) |
315 (58.6) |
| ≥126 |
41 (3.3) |
28 (68.3) |
15 (53.6) |
13 (46.4) |
| P value |
|
0.004 |
0.02 |
0.03 |
Percentages for the column of total add 100%; while for prevalence rates, the
100% is in the lines |
